FindTrial
Sign In

use of progesterone in prevention of preterm labour

RANDOMISED TRIAL OF NATURAL PROGESTERONE IN PREVENTION OF PRETERM BIRTH IN HIGH RISK WOMEN.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2008/091/000218
Enrollment
81
Registered
2008-11-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: progesterone: 100 ug vaginally for 10 weeks Control Intervention1: placebo: vaginally for 10 weeks

Sponsors

Maulana Azad Medical College, New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The inclusion criteria were pregnant women with gestational age between 24-30 weeks and previous history of preterm delivery

Exclusion criteria

Exclusion criteria: The exclusion criteria included women allergic to progesterone, with preterm rupture of membranes, multiple pregnancies, fetal malformations, progesterone intake less than two weeks, therapeutic preterm delivery, other medical disorders like diabetes mellitus, chronic renal diseases, chronic hypertension, heart disease, and severe anaemia ( defined as haemoglobin less than 7 gm% ) which predisposes to preterm delivery. Those with cervical incompetence (cervical length < 2.5 cm or funneling on ultrasound ) were also excluded from the study.

Design outcomes

Primary

MeasureTime frame
delivery more than or equal to 37 weeks of gestation.Timepoint: delivery—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDr. Asmita Muthal Rathore
asmitapraveen@vsnl.net09968604345

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026